NHS Framework - Blood Disorders including Haemophilia A and B - July 2024
Awarded by NHS England · to Pfizer Ltd · 2024-05-31T00:00:00+01:00 · £765,000,000
Description
Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024 Offer reference number: CM/PHS/22/5661 Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
- Supplier
- Pfizer Ltd
- Buyer
- NHS England
- Value
- £765,000,000
- Category (CPV)
- Pharmaceutical products
- Award date
- 2024-05-31T00:00:00+01:00
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.